Skip to main content

Table 1 Patients and tumours characteristics

From: A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers

Age (y) FIGO Grade Mutation Treatment PSMA %DAB 1 PSMA %DAB 2 Interval between samples (months) Relapse Time of relapse after CT (months) Death OS (months)
1 46 III III No Surgery—ACT 0.703 Yes 0.3 No 19.2
2 66 III III BRCA1 NACT—cytoreductive surgery—ACT 0.005 0 3.3 Yes 18.0 Yes 70.8
3 83 III III No NACT—exploratory surgery—ACT 0.109 0 3.0 Yes 7.6 No 64.7
4 58 IV III Not available NACT—exploratory surgery—ACT 0.123 0 4.0 Yes 46.6 No 69.0
5 56 III III No Surgery—ACT 0 Yes 32.0 No 84.7
6 62 III III No NACT—cytoreductive surgery—ACT 0.009 0.003 2.9 Yes 7.9 No 61.0
7 63 III III Not available NACT—cytoreductive surgery—ACT 0.017 0.081 3.7 Yes 4.7 Yes 37.5
8 61 III II Not available Surgery—ACT 0.001 Yes 10.0 Yes 49.4
9 61 III III No Surgery—ACT 0 Yes 1.0 Yes 17.8
10 61 III III Not available NACT—Progression, second line of ttt 0.003 Yes 0.8 Yes 5.5
11 55 III III No NACT—cytoreductive surgery—ACT 0.003 0 3.8 Yes 4.0 Yes 20.8
12 64 III III No NACT—cytoreductive surgery—ACT 0 0.004 3.2 Yes 13.2 Yes 45.4
13 63 III III Not available Surgery—ACT 0.028 Yes 1.1 Yes 8.5
14 73 III III No NACT—cytoreductive surgery—ACT 0 0 4.1 Yes 4.8 No 53.9
15 48 III III No NACT—exploratory surgery—ACT 0.008 0.033 4.1 Yes 3.0 Yes 16.6
16 74 IV III No NACT—cytoreductive surgery—ACT 0.036 0 3.0 Yes 14.6 Yes 46.2
17 79 III III No NACT—cytoreductive surgery—ACT 0.078 0.082 3.3 Yes 3.4 No 40.2
18 58 III III No NACT—cytoreductive surgery—ACT 0.016 0.006 3.4 Yes 9.9 Yes 23.4
19 70 III III No NACT—exploratory surgery—ACT 0.022 0.002 5.0 Yes 6.9 No 20.4
20 66 III III BRCA2 NACT—cytoreductive surgery—ACT 0.014 0.018 4.9 No No 91.0
21 48 III III BRCA1 NACT—cytoreductive surgery—ACT 0.008 0 3.2 Yes 10.6 Yes 38.1
22 65 III III Not available NACT—exploratory surgery—ACT 0.001 0 5.7 Yes 7.9 No 27.8
23 72 III II No NACT—cytoreductive surgery—ACT 0 0.428 3.7 Yes 11.0 Yes 32.7
24 76 III III No NACT—cytoreductive surgery—ACT 0.010 0.002 4.4 Yes 25.9 Yes 53.6
25 68 III III Not available NACT—cytoreductive surgery—ACT 0.002 0.008 4.1 Yes 13.9 Yes 52.1
26 66 III III No NACT—cytoreductive surgery—ACT 0.001 0.001 4.3 Yes 6.0 Yes 102.8
27 76 III III Not available NACT—exploratory surgery—ACT 0.053 0.065 6.0 Yes 2.3 Yes 8.3
28 74 III III No NACT—cytoreductive surgery—ACT 0 0.006 5.2 Yes 9.4 Yes 31.4
29 67 IV III Not available NACT—cytoreductive surgery—ACT 0.016 0.554 5.3 Yes 3.4 No 27.9
30 74 III III No NACT—cytoreductive surgery—ACT 0.019 0.049 4.7 Yes 18.2 No 47.7
31 82 III III No NACT—cytoreductive surgery—ACT 0.027 0 4.4 Yes 8.6 Yes 33.3
32 83 III III Not available Surgery—ACT 0.031 Yes 0.5 Yes 21.4
  1. CT, chemotherapy; NACT, neoadjuvant chemotherapy; ACT, adjuvant chemotherapy; ttt, treatment